Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 62
Selected: 0
NCT IDTitle
NCT00004026CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy
NCT02803762Investigate Absorption, Metabolism, Excretion, and Mass Balance of Pacritinib
NCT00661544Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients
NCT00193544Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma
NCT00069901Phase II CT-2103/Carboplatin in Ovarian Cancer
NCT00020969Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
NCT00493467Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas
NCT02807116Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy Subjects
NCT00060684Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma
NCT00352690A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer
NCT00054184Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer
NCT00487669Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)
NCT02055781Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia
NCT02808455Study to Assess the Relative Bioavailability of Pacritinib Following Oral Administration as Capsule and Solution Formulations in Healthy Subjects
NCT00054210Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
NCT02452346Study of Clinical Efficacy and Safety of Tosedostat in MDS
NCT02891603A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression
NCT01227408Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer
NCT00275067Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
NCT04884191Phase 2 Study: An Open-Label, Randomized, Phase 2 Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myelofibrosis Previously Treated With Ruxolitinib
NCT02800889Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer
NCT00017069Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
NCT01491841IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma
NCT00551239Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
NCT02564536Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)
NCT00660218A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
NCT05657613Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects
NCT01632436Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic Impairment
NCT00193518Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT01638442Crossover Trial of the Effect of a High-Fat Meal on the PK of Oral CHR 2797 in Healthy Male Subjects
NCT00234000Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
NCT00291837CT-2106 for the Second Line Treatment of Ovarian Cancer
NCT00270907CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer
NCT02469415Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS)
NCT00291785Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer
NCT02807207To Evaluate the Cardiac Safety and PK Following a Single Oral Dose Administration of Pacritinib in Healthy Subjects
NCT00106600Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)
NCT02323607Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 Mutations
NCT02823171To Assess the Bioequivalence of Two Pacritinib Drug Product Formulations and FMI Formulation Following Oral Administration in Healthy Subjects
NCT00577161Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL
NCT04404361PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer
NCT00060671Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma
NCT00088530BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)
NCT00576225CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL
NCT02765724Determine Pacritinib Pharmacokinetics in Impaired Hepatic Patients and Healthy Subjects
NCT03645824Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF)
NCT02277093Pacritinib to Inhibit JAK/STAT Signaling in Refractory Colorectal Cancer
NCT01321541Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant
NCT00269828A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
NCT05552183Study to Evaluate the Safety, Tolerability, and PK of Pacritinib